Which of the following drug has been used in the treatment of angina by the inhalation route with very rapid onset and short duration of action?
**Core Concept**
The underlying principle being tested is the management of **angina pectoris** using pharmacological agents that can be administered via the inhalation route, providing rapid relief from symptoms. This involves understanding of **nitric oxide** donors and their role in vasodilation.
**Why the Correct Answer is Right**
Given the context of rapid onset and short duration for angina treatment, the most suitable drug is one that acts as a **nitric oxide** donor, causing vasodilation and reducing myocardial oxygen demand. The correct answer is likely a drug that is commonly used for this purpose.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific drug name, we cannot provide a detailed explanation, but typically, options that do not involve **nitric oxide** donation or rapid vasodilation would be incorrect.
**Option B:** Similarly, without specifics, any option not associated with rapid relief of angina symptoms via inhalation would be wrong.
**Option C:** This option would be incorrect if it does not match the known drug used for rapid angina relief via inhalation.
**Option D:** Assuming this is not the correct drug, it would lack the necessary rapid onset and short duration characteristics.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **nitroglycerin** is a classic example of a drug used for angina, acting through **nitric oxide** donation to cause vasodilation. Its rapid onset and short duration make it ideal for acute relief.
**Correct Answer:** Correct Answer: D. Nitroglycerin.